A detailed history of Voya Investment Management LLC transactions in Mersana Therapeutics, Inc. stock. As of the latest transaction made, Voya Investment Management LLC holds 38,301 shares of MRSN stock, worth $62,047. This represents 0.0% of its overall portfolio holdings.

Number of Shares
38,301
Previous 38,588 0.74%
Holding current value
$62,047
Previous $77,000 6.49%
% of portfolio
0.0%
Previous 0.0%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$1.23 - $2.25 $353 - $645
-287 Reduced 0.74%
38,301 $72,000
Q2 2024

Dec 03, 2024

BUY
$2.0 - $4.45 $574 - $1,277
287 Added 0.75%
38,588 $77,000
Q2 2024

Aug 14, 2024

BUY
$2.0 - $4.45 $4,122 - $9,171
2,061 Added 5.64%
38,588 $77,000
Q1 2024

Dec 06, 2024

SELL
$2.16 - $5.94 $3,831 - $10,537
-1,774 Reduced 4.63%
36,527 $163,000
Q1 2024

May 15, 2024

SELL
$2.16 - $5.94 $20,532 - $56,465
-9,506 Reduced 20.65%
36,527 $163,000
Q4 2023

Feb 14, 2024

BUY
$1.11 - $2.34 $2,666 - $5,620
2,402 Added 5.51%
46,033 $106,000
Q3 2023

Nov 14, 2023

SELL
$1.06 - $3.91 $13,860 - $51,127
-13,076 Reduced 23.06%
43,631 $55,000
Q2 2023

Aug 14, 2023

SELL
$3.08 - $9.55 $1.37 Million - $4.25 Million
-445,452 Reduced 88.71%
56,707 $186,000
Q1 2023

May 15, 2023

BUY
$4.0 - $7.02 $861,060 - $1.51 Million
215,265 Added 75.03%
502,159 $2.06 Million
Q4 2022

Feb 14, 2023

BUY
$5.65 - $7.86 $268,996 - $374,214
47,610 Added 19.9%
286,894 $1.68 Million
Q3 2022

Mar 03, 2023

SELL
$4.63 - $8.0 $220,434 - $380,880
-47,610 Reduced 16.59%
239,284 $1.62 Million
Q3 2022

Nov 14, 2022

BUY
$4.63 - $8.0 $954,298 - $1.65 Million
206,112 Added 621.34%
239,284 $1.62 Million
Q2 2022

Aug 15, 2022

BUY
$2.84 - $5.0 $19,442 - $34,230
6,846 Added 26.0%
33,172 $153,000
Q4 2021

Feb 14, 2022

SELL
$5.48 - $9.86 $613 - $1,104
-112 Reduced 0.42%
26,326 $164,000
Q2 2021

Aug 16, 2021

BUY
$13.28 - $18.07 $46,320 - $63,028
3,488 Added 15.2%
26,438 $359,000
Q1 2021

May 17, 2021

SELL
$15.31 - $26.52 $1,684 - $2,917
-110 Reduced 0.48%
22,950 $371,000
Q4 2020

Feb 16, 2021

BUY
$16.84 - $27.59 $86,237 - $141,288
5,121 Added 28.55%
23,060 $614,000
Q3 2020

Nov 16, 2020

BUY
$16.2 - $25.7 $32,772 - $51,991
2,023 Added 12.71%
17,939 $334,000
Q2 2020

Aug 14, 2020

SELL
$5.24 - $23.4 $15,987 - $71,393
-3,051 Reduced 16.09%
15,916 $372,000
Q4 2019

Feb 14, 2020

BUY
$1.45 - $6.73 $8,552 - $39,693
5,898 Added 45.13%
18,967 $109,000
Q2 2019

Aug 14, 2019

BUY
$3.84 - $6.4 $50,184 - $83,641
13,069 New
13,069 $53,000

Others Institutions Holding MRSN

About Mersana Therapeutics, Inc.


  • Ticker MRSN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 97,169,296
  • Market Cap $157M
  • Description
  • Mersana Therapeutics, Inc., a clinical stage biopharmaceutical company, develops antibody drug conjugates (ADC) for cancer patients with unmet need. It develops XMT-1592, a Dolasynthen ADC targeting NaPi2b-expressing tumor cells, which is in phase I clinical trial for the treatment of ovarian cancer and NSCLC adenocarcinoma. The company also dev...
More about MRSN
Track This Portfolio

Track Voya Investment Management LLC Portfolio

Follow Voya Investment Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Voya Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Voya Investment Management LLC with notifications on news.